Dr. Clelland received her PhD in molecular genetics from the Institute of Child Heath/Great Ormond Street Hospital, at University College London, London, England. She completed her postdoctoral training and an Instructorship at Mount Sinai School of Medicine, New York. In 2007, Dr. Clelland became a faculty member of the Taub Institute for Research on Alzheimer's Disease and the Aging Brain at Columbia University Medical Center. Upon joining Columbia, she was awarded a National Institutes of Health KL2 Mentored Career grant through the Columbia Clinical and Translational Science Award, and under the auspices of this award she completed a MS in Biostatistics, in the Patient Oriented Research Track. She was a recipient of a Gray Matters at Columbia Fellowship, and has received further grants from the National Institute of Mental Health, the National Institute of Aging, the BrightFocus Foundation, the Stanley Medical Research Institute, and the Department of Defense. Dr. Clelland’s research focuses on identification of molecular pathways in patients with neuropsychiatric illnesses such as Alzheimer’s Disease and schizophrenia, aiming to understand disease susceptibility, the onset of symptoms, and illness progression, as well as to identify novel treatment targets.